Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05569005 · ClinicalTrials.gov registry record · NA
Effect of Switching From Cigarette Smoking to THS on Disease Progression in Mild to Moderate COPD Subjects With Chronic Bronchitis Symptoms.
A NA study, sponsored by Philip Morris Products S.A..
- Terminated
- Registry status
- NA
- Development phase
- 715
- Enrollment target
NCT05569005 is a NA study that was terminated before completion, run by Philip Morris Products S.A.. The registered enrollment target is 715 participants.
The verdict
NCT05569005, a NA study, was terminated before completion, sponsored by Philip Morris Products S.A..
- TERMINATED
- Registry status
- NA
- Development phase
- 715 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the slowing of the disease progression including the improvement of Chronic Obstructive Pulmonary Disease (COPD) symptoms in smoking subjects with mild to moderate COPD and a history of chronic bronchitis symptoms (sputum and cough) who switch to the Tobacco Heating System (THS) as compared to those who continue to smoke cigarettes.
Interventions
- OTHER Cigarette
- OTHER Smoking Abstinence
- OTHER THS use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 715 participants |
| Start Date | 2022-12-16 |
| Est. Completion | 2024-09-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05569005
The ClinicalTrials.gov registry entry for NCT05569005 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 715 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philip Morris Products S.A., which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cigarette is the first listed.
NCT05569005 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05569005 about?
NCT05569005 is a clinical study titled "Effect of Switching From Cigarette Smoking to THS on Disease Progression in Mild to Moderate COPD Subjects With Chronic Bronchitis Symptoms.". The purpose of this study is to demonstrate the slowing of the disease progression including the improvement of Chronic Obstructive Pulmonary Disease (COPD) symptoms in smoking subjects with mild to moderate COPD and a history of chronic bronchitis symptoms (sputum and cough) who switch to the Tobac...
What is the current status of trial NCT05569005?
This trial is currently terminated. It is a NA study. The enrollment target is 715 participants. The study started on 2022-12-16. Estimated completion is 2024-09-13.
What interventions are being tested in trial NCT05569005?
The interventions under investigation include: Cigarette (OTHER), Smoking Abstinence (OTHER), THS use (OTHER).
Who is sponsoring clinical trial NCT05569005?
This trial is sponsored by Philip Morris Products S.A., which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.